EFFECT OF CYCLOSPORINE TIME IN THERAPEUTIC RANGE ON CELLULAR REJECTION IN 1 YEAR AFTER HEART TRANSPLANTATION

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20240319005

Enrollment

Registered

2024-03-19

Start date

2023-03-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

This was a single-center retrospective cohort study. Adult HTRs at King Chulalongkorn Memorial Hospital (KCMH) between January 1, 2009, and December 31, 2021, who were maintained on CsA within the first year of HT were analyzed. Heart transplantation Cyclosporine Acute cellular rejection

Interventions

Based on the median therapeutic range of cyclosporine, the recipients were divided into low time in therapeutic range of cyclosporine,Based on the median therapeutic range of cyclosporine, the recipie

Treatment,Treatment

Low CsA TTR,High CsA TTR

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: This was a single-center retrospective cohort study. Adult HTRs at King Chulalongkorn Memorial Hospital (KCMH) between January 1, 2009, and December 31, 2021, who were maintained on cyclosporine within the first year of HT were analyzed.

Exclusion criteria

Exclusion criteria: Recipients who were initial calcineurin inhibitors other than CsA, combined heart and other organ transplant, with organ transplant history, were excluded

Design outcomes

Primary

Measure	Time frame
Acute cellular rejection 1 year Time to event	—

Secondary

Measure	Time frame
n/a n/a n/a	—

Countries

Thailand

Contacts

Public ContactWatsit Chaipatiwat

Faculty of Pharmaceutical Sciences, Chulalongkorn University

Watsit8149@gmail.com0957713322

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026